BrainKey

BrainKey

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $18.2M

Overview

BrainKey is a private, pre-revenue AI neuroimaging diagnostics company building a software platform to extract actionable insights from brain MRI scans. Founded by neuroscientist Dr. Owen Philips and backed by Y Combinator, the company leverages advanced machine learning to identify and visualize key biomarkers, aiming to make complex anatomical data accessible for physicians and patients. Its mission is to provide tools for the early assessment of brain health, targeting the massive unmet need in neurological and psychiatric care, particularly in the context of rising dementia prevalence. The company is in the development and early commercial validation stage, offering scans and analysis directly or through partnerships.

NeurologyPsychiatry

Technology Platform

AI/ML platform for quantitative analysis of brain MRI scans, generating biomarkers and interactive 3D visualizations of individual brain anatomy.

Funding History

2
Total raised:$18.2M
Series A$15M
Seed$3.2M

Opportunities

The massive and growing prevalence of dementia and neurological disorders creates a urgent need for early, objective biomarkers.
The shift towards preventive care and patient empowerment aligns perfectly with BrainKey's mission to provide accessible, quantitative brain health insights.

Risk Factors

The company faces significant regulatory hurdles to get FDA clearance for clinical claims, and must prove clinical utility and secure insurance reimbursement for widespread adoption.
Competition in the AI medical imaging space is intense and rapidly evolving.

Competitive Landscape

BrainKey competes in the growing AI neuroimaging market against both large medical imaging corporations (GE, Siemens) integrating AI and a multitude of startups (e.g., Viz.ai, Cortechs.ai, Icometrix). Its differentiation lies in its focus on individual-level analysis, strong neuroscience research pedigree, and emphasis on patient-facing visualizations.